Medicare reminds healthcare providers of an important coverage change through claims denials. Ever since a public health emergency (PHE) for COVID-19 was declared on Jan. 27, 2020, there has been several new HCPCS Level II codes created for monoclonal antibody (mAb) products and administration. As confusing as all these new codes and billing requirements have […]
The post COVID-19 Monoclonal Antibody Billing Update appeared first on AAPC Knowledge Center.